Anke R. S.
- Country
- Germany
- Department
- St. Joseph Hospital Bochum, Med. Klinik I
Research Overview
- Evaluation of Safety and Efficacy of Targeted Therapies in Metastatic Colorectal Cancer Subpopulations
- Pumitamig and Combination Therapy Versus Bevacizumab and Combination Therapy in Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase II Open‑Label Multicenter Study of Subcutaneous Epcoritamab in Relapsed/Refractory Marginal Zone Lymphoma (EPOS‑1)
Data & Insights
Has run more than one trial at 307 of 607 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced gastrointestinal cancers, with particular focus on gastroesophageal junction adenocarcinoma and colorectal cancer.
- Esophagogastric Cancer Treatment
- Metastatic Colorectal Cancer Management
- Advanced Rectal Cancer Therapies
Research activities concentrate on innovative treatment approaches combining surgical intervention with systemic therapies.
Pancreatic Cancer Research
Dedicated to advancing treatment options for pancreatic ductal adenocarcinoma, including both resectable and metastatic disease states.
- Oligometastatic Pancreatic Cancer Treatment
- Novel Therapeutic Combinations
- Personalized Treatment Approaches
Expertise in developing multimodal treatment strategies incorporating surgical and medical interventions.
Precision Oncology
Focuses on biomarker-driven treatment approaches and targeted therapies across multiple cancer types.
- Molecular-Based Treatment Selection
- Circulating Tumor DNA Analysis
- Immunotherapy Applications
Implements innovative diagnostic strategies to optimize treatment selection and patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.